不同发育潜能卵丘-卵母细胞复合体来源人卵丘细胞的代谢组学分析
研究比较了三组已知发育潜能的卵丘-卵母细胞复合体(未形成囊胚组、形成囊胚但未妊娠组、形成囊胚并妊娠组)来源的卵丘细胞代谢组,每组12个样本。非靶向代谢组学分析鉴定出98种化合物,其中5种在组间差异丰度(P<0.05)。丙二酸、5-氧脯氨酸和苏糖酸在最终建立妊娠的复合体卵丘细胞中丰度更高,但与供者年龄和BMI无显著关联。
要点
- 丙二酸、5-氧脯氨酸和苏糖酸在建立妊娠的卵丘细胞中丰度更高。
- 5种化合物在发育潜能不同的组间差异丰度(P<0.05)。
- 化合物丰度与供者年龄或BMI无显著关联。
核心结论
- 丙二酸、5-氧脯氨酸和苏糖酸在最终建立妊娠的卵丘-卵母细胞复合体的卵丘细胞中丰度显著更高,为卵母细胞发育潜能所需通路提供线索。
研究设计与样本
- 研究纳入三组已知发育潜能的卵丘-卵母细胞复合体:ICSI后未发育至囊胚组(Bl-)、发育至囊胚但胚胎移植后未妊娠组(P-)、发育至囊胚并建立妊娠组(P+),每组12个样本,每个样本为单个复合体回收的卵丘细胞。
- 卵丘细胞样本来自IVF治疗,仅纳入未冷冻且未进行胚胎植入前遗传学检测的卵母细胞和胚胎。
- 代谢组学分析采用超高效液相色谱-串联质谱法。
主要发现
- 分析共鉴定出98种化合物,其中5种在组间差异丰度(P<0.05)。
- 天冬酰胺、脯氨酸和丙二酸在P-组较Bl-组丰度更低,丙二酸和5-氧脯氨酸在P-组较P+组丰度更低,苏糖酸在Bl-组较P+组丰度更低。
- 未发现所鉴定化合物丰度与供者年龄或BMI之间存在显著关联。
- 非靶向分析发现了卵丘细胞中未曾预期的化合物,如β-柠檬酰谷氨酸和神经递质N-乙酰-天冬氨酰-谷氨酸,后者可能分别参与染色质重塑和信号传导。
临床怎么用
- 原文未据此给出推荐。
局限性
- 数据离散度大且发育组间缺乏一致性,妨碍代谢标志物直接用于临床实践,其中子宫环境对妊娠结局起主要作用。
- 分析未检测到的其他化合物丰度可能与卵母细胞发育潜能相关。
- 供者均为瘦型(仅两例BMI>30 kg/m2)且年轻(<34岁),无法确定肥胖或高龄对卵丘细胞代谢组的可能影响。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
STUDY QUESTION: Is the abundance of certain biochemical compounds in human cumulus cells (CCs) related to oocyte quality? SUMMARY ANSWER: Malonate, 5-oxyproline, and erythronate were positively associated with pregnancy potential. WHAT IS KNOWN ALREADY: CCs are removed and discarded prior to ICSI, thereby constituting an interesting biological material on which to perform molecular analysis aimed to predict oocyte developmental competence. Mitochondrial DNA content and transcriptional analyses in CC have been shown to provide a poor predictive value of oocyte competence, but the untargeted analysis of biochemical compounds (metabolomics) has been unexplored. STUDY DESIGN, SIZE, DURATION: CCs were obtained from three groups of cumulus-oocyte complexes (COCs) of known developmental potential: oocytes not developing to blastocyst following ICSI (Bl-); oocytes developing to blastocyst but failing to establish pregnancy following embryo transfer (P-); and oocytes developing to blastocyst able to establish a pregnancy (P+). Metabolomics analyses were performed on 12 samples per group, each sample comprising the CC recovered from a single COC. PARTICIPANTS/MATERIALS, SETTING, METHODS: Human CC samples were obtained from IVF treatments. Only unfrozen oocytes and embryos not submitted to preimplantation genetic testing were included in the analysis. Metabolomics analysis was performed by ultra-high performance liquid chromatography-tandem mass spectroscopy. MAIN RESULTS AND THE ROLE OF CHANCE: The analysis identified 98 compounds, five of which were differentially abundant (P < 0.05) between groups: asparagine, proline, and malonate were less abundant in P- compared to Bl-, malonate and 5-oxoproline were less abundant in P- group compared to P+, and erythronate was less abundant in Bl- group compared to P+. No significant association between the abundance of the compounds identified and donor age or BMI was noted. LIMITATIONS, REASONS FOR CAUTION: Data dispersion and the lack of coherence between developmental groups preclude the direct use of metabolic markers in clinical practice, where the uterine environment plays a major role in pregnancy outcome. The abundance of other compounds not detected by the analysis may be associated with oocyte competence. As donors were lean (only two with BMI > 30 kg/m2) and young (<34 years old), a possible effect of obesity or advanced age on the CC metabolome could not be determined. WIDER IMPLICATIONS OF THE FINDINGS: The abundance of malonate, 5-oxyproline, and erythronate in CC was significantly higher in COCs ultimately establishing pregnancy, providing clues on the pathways required for oocyte competence. The untargeted analysis uncovered the presence of compounds that were not expected in CC, such as β-citrylglutamate and the neurotransmitter N-acetyl-aspartyl-glutamate, which may play roles in chromatin remodeling and signaling, respectively. STUDY FUNDING/COMPETING INTEREST(S): Research was supported by the Industrial Doctorate Project IND2017/BIO-7748 funded by Madrid Region Government. The authors declare no competing interest. TRIAL REGISTRATION NUMBER: N/A.
引用
- Martínez-Moro Á, González-Brusi L, Querejeta-Fernández A, et al. Metabolomics analysis of human cumulus cells obtained from cumulus-oocyte complexes with different developmental potential. Hum Reprod. 2023. PMID: 37697661. doi:10.1093/humrep/dead181
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。